Therapeutic Management of Ocular Disease

Subject OPTO40007 (2010)

Note: This is an archived Handbook entry from 2010.

Credit Points: 12.50
Level: 4 (Undergraduate)
Dates & Locations:

This subject has the following teaching availabilities in 2010:

Semester 2, Parkville - Taught on campus.
Pre-teaching Period Start not applicable
Teaching Period not applicable
Assessment Period End not applicable
Last date to Self-Enrol not applicable
Census Date not applicable
Last date to Withdraw without fail not applicable


Timetable can be viewed here. For information about these dates, click here.
Time Commitment: Contact Hours: 12 x one hour lectures, 6 x two hour Computer Aided Learning practicals, and 12 x two hour seminars during the semester
Total Time Commitment: Estimated total time commitment of 120 hours
Prerequisites: Both of
Subject
Study Period Commencement:
Credit Points:
Corequisites: Both of
Subject
Study Period Commencement:
Credit Points:
Recommended Background Knowledge: None
Non Allowed Subjects: None
Core Participation Requirements: It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. Students who feel their disability may impact upon their active and safe participation in a subject are encouraged to discuss this with the relevant subject coordinator and the Disability Liaison Unit.

Coordinator

Dr Alex Gentle

Contact

Email: agentle@unimelb.edu.au

Subject Overview:

The subject will consist of three components: Firstly, a lecture series to guide the student on the formulations available, the indications and contra-indications for their use and the current clinical protocols employed in the use of these formulations. Lecture topics covered will include anti-microbial, anti-viral, anti-inflammatory and anti-glaucoma medications; Secondly, a series of CAL practical sessions in which the student will be encouraged to apply knowledge gained in the lectures to a theoretical series of clinical situations; Thirdly, a series of seminars on the therapeutic management of ocular disease in which the students will prepare and present their management strategies in response to a variety of case histories and the supervising clinician will discuss current best-practice management associated with these cases and highlight issues associated with incorrect diagnosis. By the end of this subject the student will be required to have demonstrated a sound theoretical knowledge of the range and application of specific groups of therapeutic drugs in the management of eye disease.
Objectives: The purpose of this subject is to provide students with a sound knowledge of the range of prescription drugs used in the management of eye disease, along with the appropriate protocols and precautions necessary for their safe and effective clinical use.
Assessment:

A 10-minute oral presentation on a case report during the semester (20%); computer-aided learning assignments due during the semester (20%); a 2-hour written examination in the examination period (60%). An attendance rate of at least 80% is a hurdle requirement for each student for the Ophthalmology Seminar Series.
Prescribed Texts:
  • D Y Kunimoto et al, The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th Ed, Lippincott, Williams and Wilkins, 2008 (or 4th edition)
Recommended Texts:
  • A S Bruce and M S Loughnan, Anterior Eye Disease and Therapeutics A-Z, Butterworth Heinemann, 2003
  • Australian Medicines Handbook (AMH) , Latest Edition
Breadth Options:

This subject is not available as a breadth subject.
Fees Information: Subject EFTSL, Level, Discipline & Census Date
Notes:

This subject is only available to Bachelor of Optometry students.
Related Course(s): Bachelor of Optometry

Download PDF version.